PALM BEACH GARDENS, Fla., June 24, 2025 /PRNewswire/ — A second child has died after receiving Elevidys, an experimental gene therapy for Duchenne muscular dystrophy—raising serious concerns about regulatory shortcuts, patient safety, and the urgent need for oversight. In a new article,…